Quantcast

Latest Organ failure Stories

2014-05-29 08:28:45

Heart failure is the second leading cause of hospitalization of Canadians over 65 and responsible for nine per cent of all deaths MONTREAL, May 29, 2014 /CNW/ - Canada's leading cardiologists and other health professionals interested in heart failure are meeting in Montreal this weekend at the Heart Failure Update 2014 meeting to examine the newest developments in heart failure, a condition responsible for nine per cent of all deaths in Canada.(i) The burden of heart failure is...

2014-05-28 16:26:48

ATLANTA, May 28, 2014 /PRNewswire/ -- Arcapita Ventures announced today that CardioMEMS, Inc. has received U.S. FDA (Food and Drug Administration) approval for its Heart Failure Management System. The approval is based upon the results of the CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Patients) clinical trial which demonstrated a 28% reduction in the primary efficacy endpoint of heart failure hospitalization rates at 6 months,...

2014-05-22 23:16:21

New book tells of an extraordinary comeback from kidney failure to good health. London (PRWEB) May 22, 2014 Adeleke Eniola Oyenusi’s recovery from kidney failure inspired him to write his new book “Living a Normal and Healthy Life after Renal (Kidney) Failure” (published by Trafford Publishing) to encourage and educate other renal patients with little or no knowledge about the condition. “I asked my wife to quickly rush me to the hospital when I became breathless and feared I...

2014-05-19 12:31:37

European Society of Cardiology Worsening symptoms and signs of heart failure in patients admitted to a hospital is a common sign of treatment failure Worsening symptoms and signs of heart failure (WHF) in patients admitted to a hospital is a common sign of treatment failure and can lead to long-term consequences for the patient, including longer length of hospitalization and a higher risk for readmission and death, according to a late-breaking study (RELAX-AHF, PROTECT) presented in...

2014-05-19 11:42:51

European Society of Cardiology Sleeping pills increase the risk of cardiovascular events in heart failure patients by 8-fold, according to research from Japan. The study was presented today at the Heart Failure Congress 2014, held 17-20 May in Athens, Greece. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology. Dr Masahiko Setoguchi said: "Sleeping problems are a frequent side effect of heart failure and it is common for...

2014-05-15 08:33:06

Completes Enrollment in Phase 2b Clinical Trial of CLP-1001 for Heart Failure SUNNYVALE, Calif., May 15, 2014 /PRNewswire/ -- Sorbent Therapeutics, Inc., a biopharmaceutical company developing therapies for cardiovascular and renal diseases, today announced the closing a $6.5 million tranche in a $15 million Series D financing. Existing investors CMEA Capital, ARCH Venture Partners, Sofinnova Ventures, AgeChem and Novartis Venture Funds participated in the round. Sorbent also...

2014-05-14 16:28:26

RIVER EDGE, N.J., May 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today that John C. Houghton, President and Chief Executive Officer, will present at the Third Annual Marcum MicroCap Conference in New York on Thursday, May 29, 2014 at 3:30 p.m. EDT....

2014-05-13 23:16:04

Avail is conducting a phase 1, single dose, parallel group study to evaluate the pharmacokinetics of an experimental drug in subjects with impaired renal function. DeLand, FL (PRWEB) May 13, 2014 *To see if you qualify for this Renal Impairment Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance is required, and you may receive compensation for time and...

2014-05-13 16:28:05

RIVER EDGE, N.J., May 13, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today the first commercial use of its hemodiafiltration ("HDF") system in the United States. As announced in a separate press release today, DaVita Kidney Care, a division of DaVita...

2014-05-12 23:06:28

All Natural Kidney Health and Kidney Function Restoration Program is a new brand treatment method that includes natural and safe remedies to improve kidney function and reverse kidney disease. A complete All Natural Kidney Health and Kidney Function Restoration Program review on the website hynguyenblog.com shows whether this method is useful or not. Seattle, WA (PRWEB) May 12, 2014 All Natural Kidney Health and Kidney Function Restoration Program is the newest method, which gives users...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related